Cargando…
Diagnostic efficacy of systemic immune-inflammation biomarkers in benign prostatic hyperplasia using receiver operating characteristic and artificial neural network
Benign prostatic hyperplasia (BPH) is a chronic, progressive disease characterized by mesenchymal cell-predominance and stromal and glandular cell-hyperproliferation. Although, the precise cause of BPH is unknown, it is believed to be associated with hormonal changes in aging men. Despite androgens...
Autores principales: | Ahmed, Rasha, Hamdy, Omnia, Awad, Refaat Mostafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491602/ https://www.ncbi.nlm.nih.gov/pubmed/37684320 http://dx.doi.org/10.1038/s41598-023-41781-3 |
Ejemplares similares
-
Current Applications of Artificial Intelligence in Benign Prostatic Hyperplasia
por: Shah, Milap, et al.
Publicado: (2022) -
Benign Prostatic Hyperplasia
Publicado: (2015) -
The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia
por: Cakir, Suleyman Sami, et al.
Publicado: (2018) -
Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity
por: Stephan, Carsten, et al.
Publicado: (2008) -
The Effect of Intraprostatic Chronic Inflammation on Benign Prostatic Hyperplasia Treatment
por: Kwon, Young Kee, et al.
Publicado: (2010)